Stay up to date with news and events

uniQure gets the green light to resume testing HD gene therapy

November 5, 2022

In August 2022, uniQure announced a pause in new recruitment for their trial of AMT-130, an HD gene therapy delivered via brain surgery. The decision…

WAVE Announcement

October 1, 2021

Wave Life Sciences Announces Initiation of Dosing in Phase 1b_2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease